Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015

Emerg Infect Dis. 2017 Oct;23(10):1703-1706. doi: 10.3201/eid2310.170106.

Abstract

We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan during 2008-2015. The highest prevalence of macrolide-resistant M. pneumoniae was 81.6% in 2012, followed by 59.3% in 2014 and 43.6% in 2015. The prevalence of macrolide-resistant M. pneumoniae among children in Japan has decreased.

Keywords: Japan; Mycoplasma pneumoniae; antimicrobial resistance; bacteria; children; drug resistance; macrolides; real-time PCR.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Drug Resistance, Bacterial / genetics*
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Japan / epidemiology
  • Macrolides / therapeutic use*
  • Male
  • Microbial Sensitivity Tests
  • Mutation Rate
  • Mycoplasma pneumoniae / classification
  • Mycoplasma pneumoniae / drug effects
  • Mycoplasma pneumoniae / genetics*
  • Mycoplasma pneumoniae / isolation & purification
  • Pneumonia, Mycoplasma / drug therapy*
  • Pneumonia, Mycoplasma / epidemiology*
  • Pneumonia, Mycoplasma / microbiology
  • Prevalence
  • RNA, Ribosomal, 23S / genetics*

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • RNA, Ribosomal, 23S